4Machado A H, Soares C P, Behrame-Junior M, et al. Cytotoxicity of oc tal-bromide zinc phthalocyanine after photodynamic therapy with different light sources[J]. Photomed Laser Surg, 2008, 26(5) : 455 -459.
5Huygens A, Kamuhabwa A R, Van-Laethem A, et al. Enhancing the photodynamic effect of hyperlcin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation [ J]. Int J Oneol, 2005, 26(6) : 1691 -1697.
6Olivo M, Du H Y, Bay B H. Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy [ J ]. Curr Clin Pharmacol, 2006, 1 (3) : 217 -222.
7Dewi N A, Yuzawa M, Tochigi K, et al. Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area[J]. Jpn J Ophthalmol, 2008, 52 (4) : 277 - 281.
8Quiney C, Billard C, Mirshahi P, et al. Hyperforin inhibits MMP-9 secretion by B-CLL cells and microtubule formation by endothelial cells[J]. Leukemia, 2006, 20(4): 583-589.
9Chen B, Xu Y, Roskams T, et al. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model [J]. Int J Cancer, 2001, 93(2): 275-282.
10Gold M H. Introduction to photodynamie therapy: early experience [J]. Dermatol Clin, 2007, 25(1): 1 -4.
